GRAIL

Today begins a new chapter for GRAIL as an independent, publicly traded company. We will be listed under $GRAL on Nasdaq as of the market open June 25. Learn more: https://bit.ly/3S4T1H9

Early cancer screening can be a key component of staying on top of our health. Join us on LinkedIn Live and learn why John Hancock decided to offer multi-cancer early detection (MCED) testing to their customers, and the impact it has had. Learn more and RSVP today: https://bit.ly/4hsKCrL #MCED #CancerScreening

We will issue financial results for the third quarter 2024 on Tuesday, November 12, 2024. Register for the live teleconference: https://bit.ly/40Hjn7d See more details: https://bit.ly/48ucIz6

At their doctor’s recommendation, Rich and Staci each took a multi-cancer early detection test during a routine checkup. Despite having no symptoms, Rich received a Cancer Signal Detected result, while his wife Staci, who had a strong family history of cancer, did not. 🎧 Listen to #TheCancerSignal podcast to hear Rich and Staci share a powerful reminder about proactive screening. Apple Podcasts: https://apple.co/3YGdrtr Spotify: https://spoti.fi/4hqzMCQ Amazon Music: https://amzn.to/3AqML6D

Tune in to our LinkedIn Live event, “The Cutting Edge of Wellness Programs: Early Cancer Detection.” John Hancock Chief Marketing Officer Lindsay Hanson will discuss why multi-cancer early detection testing has become a key part of their offering to customers. RSVP here: https://bit.ly/4fmtcv7 Lindsay Hanson Megan P. Hall #MCED #CancerScreening

The Tigerlily Foundation recently honored GRAIL with its "Maverick Award". Tigerlily describes mavericks as those who are unconventional, game changers, who go against the grain to achieve a way of doing things that's not usual. Simply put, a maverick shakes things up. When presenting the award, Tigerlily recognized GRAIL with the following remarks: “Through their relentless dedication, GRAIL is changing the trajectory of cancer mortality as we know it and their commitment to the non-profit community deserves special recognition. It is with great pride that we honor GRAIL with the Tigerlily Foundation Maverick Award, recognizing this inspirational work in support of those touched by cancer.”

News from the Early Detection of Cancer Conference #EdxConf24: The initial results from the REFLECTION study provide important insights into the impact of multi-cancer early detection (MCED) testing to help transform cancer screening in a real-world setting. https://bit.ly/4eTDuTz

We are proud to announce the appointment of Sarah Krevans to GRAIL’s Board of Directors. Ms. Krevans brings to this position extensive experience from her career in healthcare, including her former role as president and CEO of Sutter Health. Learn more: https://bit.ly/3YfwIkf

While there is currently no recommended screening test for liver cancer, multi-cancer early detection (MCED) testing can help screen for liver cancer and other cancers, potentially before symptoms appear. Learn more about the potential of MCED testing: https://bit.ly/406n7i7 #LiverCancerAwarenessMonth

Mike scheduled his multi-cancer early detection (MCED) test at Mercy after his doctor’s recommendation. Three weeks later, he received a call from a nurse revealing the test result: a Cancer Signal Detected with a predicted origin in his head and neck. Watch Mike sit down with an oncologist, Dr. Daniel Mackey, as he shares more about the MCED test-taking process and what happens next: https://bit.ly/4eDH9oB